NDC 29978-588

Aquanaz PSE

Dextromethorphan Hbr, Guafenesin, Pseudoephedrine Hcl

Aquanaz PSE is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Capital Pharmaceutical, Llc. The primary component is Dextromethorphan Hydrobromide; Guaifenesin; Pseudoephedrine Hydrochloride.

• Product ID: 29978-588_a50074cd-d831-ca26-e053-2a95a90a6bc9
• NDC: 29978-588
• Product Type: Human Otc Drug
• Proprietary Name: Aquanaz PSE
• Generic Name: Dextromethorphan Hbr, Guafenesin, Pseudoephedrine Hcl
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2020-05-01
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Capital Pharmaceutical, LLC
• Substance Name: DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/1; mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 29978-588-90

90 TABLET in 1 BOTTLE (29978-588-90)

• Marketing Start Date: 2020-05-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 29978-588-90 [29978058890]

Aquanaz PSE TABLET

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2020-05-01

Drug Details